Senza
Commercial- Indications
- Chronic back pain, Chronic leg pain
Company intelligence / Profile preview
Nuvectra
Plano, Texas, United Statesfacebook.com ↗
- Ownership
- Private
- Employees
- ~18
- Development stage
- Commercial
01
Overview
Nuvectra commercialized the Algovita spinal cord stimulation system for chronic pain, achieving FDA and CE Mark approvals. The company also developed Virtis for sacral neuromodulation targeting urinary disorders. Despite initial growth and clinical adoption, financial difficulties led to Chapter 11 bankruptcy in late 2019 and subsequent liquidation in 2020. The Algovita device had over 2,000 implantations in the US before operations ceased.
- Therapeutic areas
- NephrologyNeurologyUrology
- Modalities
- DeviceNeuromodulation therapy
- Industry
- Therapeutic Medical Devices
02
Drug pipeline
1 asset03
Partnerships
Aleva Neurotherapeutics – licensed Nuvectra’s platform for deep brain stimulation applicationsManufacturing partnership with Integer Holdings Corporation/Greatbatch Inc.
Beyond the preview
Go deeper on Nuvectra.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nuvectra.